74 related articles for article (PubMed ID: 15845394)
1. Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease.
Noda K; Kitami T; Gai WP; Chegini F; Jensen PH; Fujimura T; Murayama K; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 May; 331(1):309-17. PubMed ID: 15845394
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
Hattori N; Machida Y; Noda K
Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
[TBL] [Abstract][Full Text] [Related]
3. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.
Yaron A; Hatzubai A; Davis M; Lavon I; Amit S; Manning AM; Andersen JS; Mann M; Mercurio F; Ben-Neriah Y
Nature; 1998 Dec; 396(6711):590-4. PubMed ID: 9859996
[TBL] [Abstract][Full Text] [Related]
4. In vitro SCFbeta-Trcp1-mediated IkappaBalpha ubiquitination assay for high-throughput screen.
Xu S; Patel P; Abbasian M; Giegel D; Xie W; Mercurio F; Cox S
Methods Enzymol; 2005; 399():729-40. PubMed ID: 16338392
[TBL] [Abstract][Full Text] [Related]
5. IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2.
Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Suzuki T; Ichiyama A; Ikenoue T; Omata M; Furuichi K; Tanaka K
Biochem Biophys Res Commun; 1999 Mar; 256(1):127-32. PubMed ID: 10066435
[TBL] [Abstract][Full Text] [Related]
6. Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells.
Shi Z; Wu X; Ke Y; Wang L
Dig Dis Sci; 2016 Mar; 61(3):785-94. PubMed ID: 26520111
[TBL] [Abstract][Full Text] [Related]
7. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
[TBL] [Abstract][Full Text] [Related]
8. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
[TBL] [Abstract][Full Text] [Related]
9. Structural studies on 24P-IkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaB.
Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Sonois V; Benarous R; Girault JP
Biochemistry; 2007 Mar; 46(11):2958-72. PubMed ID: 17319651
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination.
Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Furuichi K; Tanaka K
Biochem Biophys Res Commun; 1999 Mar; 256(1):121-6. PubMed ID: 10066434
[TBL] [Abstract][Full Text] [Related]
11. The p97-UFD1L-NPL4 protein complex mediates cytokine-induced IκBα proteolysis.
Li JM; Wu H; Zhang W; Blackburn MR; Jin J
Mol Cell Biol; 2014 Feb; 34(3):335-47. PubMed ID: 24248593
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells.
O'Connor S; Markovina S; Miyamoto S
Exp Cell Res; 2005 Jul; 307(1):15-25. PubMed ID: 15922723
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
15. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein--implications for Parkinson's disease.
Marx FP; Soehn AS; Berg D; Melle C; Schiesling C; Lang M; Kautzmann S; Strauss KM; Franck T; Engelender S; Pahnke J; Dawson S; von Eggeling F; Schulz JB; Riess O; Krüger R
FASEB J; 2007 Jun; 21(8):1759-67. PubMed ID: 17327361
[TBL] [Abstract][Full Text] [Related]
16. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
17. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
18. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
Lim KL; Dawson VL; Dawson TM
Neurobiol Aging; 2006 Apr; 27(4):524-9. PubMed ID: 16213628
[TBL] [Abstract][Full Text] [Related]
19. Generation of a proteolytic signal: E3/E2-mediated polyubiquitination of IκBα.
Chong RA; Wu K; Kovacev J; Pan ZQ
Methods Mol Biol; 2015; 1280():339-54. PubMed ID: 25736759
[TBL] [Abstract][Full Text] [Related]
20. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
